Navigation Links
Vanda Pharmaceuticals Reports Third Quarter 2010 Results
Date:11/3/2010

>

0.11

0.05

0.06

120%Diluted net income per share attributable to common stockholders

0.11

0.04

0.07

175%Total cash and marketable securities

202,060,000

207,117,000

(5,057,000)

-2%(1)  Unaudited

OPERATIONAL HIGHLIGHTS   Year-to-date net sales of Fanapt® were reported by Novartis to be approximately $26.3 million, comprised of $20.7 million in the first quarter of 2010, $0.7 million in the second quarter of 2010 and $4.9 million in the third quarter of 2010.  Vanda is encouraged by the continuing growth in the total number of monthly prescriptions, as reported by IMS. According to IMS, monthly prescriptions of Fanapt® increased from over 4,000 in June of 2010 to over 6,000 in September of 2010.

The development of the iloperidone depot formulation is ongoing with Vanda retaining the rights for commercialization outside the U.S. and Canada.  On October 28, 2010, the U.S. Patent and Trademark Office (USPTO) informed Vanda that it has granted an additional patent term adjustment of 59 days, making the total extension 664 days and making the patent expiration date August 25, 2023.

Vanda continues to explore the regulatory path and commercial opportunity for Fanapt® oral formulation outside of the U.S. and Canada.  On November 1, 2010, Australia's Department of Health and Ageing -- Therapeutic Goods Administration, accepted for evaluation Vanda's application for marketing approval.

Enrollment has begun in Study VP-VEC-162-3201, a 160-patient randomized controlled trial of tasimelteon versus placebo in the treatment of Non-24-Hour Sleep/Wake Disorder (N24HSWD) in blind individuals with no light perception. Top-line results are expected in late 2011. The trial has a 6-month treatment period and includes measures of both nighttime and daytime sleep, as well as laboratory measures of the synchronization between the inte
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
2. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
3. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
4. Vanda Presents Phase III Iloperidone Efficacy Data
5. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
6. Vanda Pharmaceuticals Provides Update on Iloperidone
7. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
8. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
10. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
11. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Eli Lilly and Company (NYSE: ... scams, purportedly using the name of the company and/or ... the public through postal mail solicitations and job-seekers through ... any foreign lottery organizations and do not conduct the ... of the scam. The activities described in these scams ...
(Date:6/19/2013)... NEW YORK , June 19, ... announces that a new market research ... Partnerships, Licensing, Investments ... May 2013 in Pharmaceuticals ... Licensing, Investments and M&A Deals and ...
(Date:6/19/2013)... , June 19, 2013 ... Philips under de kommande tre åren kommer att ... påskynda övergången till cirkulär ekonomi. Efter ... Kingfisher och National Grid, kommer Philips att ansluta ... inom cirkulär ekonomi i sin egen verksamhet och ...
Breaking Medicine Technology:Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests 2Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 2Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 3Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 4Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 5Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 6Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 7Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 8Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 9Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 10Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 11Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 12Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 13Ellen MacArthur Foundation presenterar Philips som global partner vid det konstituerande internationella toppmötet om cirkulär ekonomi 2Ellen MacArthur Foundation presenterar Philips som global partner vid det konstituerande internationella toppmötet om cirkulär ekonomi 3
(Date:6/20/2013)... Minnesota (PRWEB) June 20, 2013 Emotional ... new book about indentifying and confronting tactics used by ... experience with emotional abuse and not being spoken to ... and shamed. She experienced these behaviors and more ... She stayed in the marriage for 13 years because ...
(Date:6/20/2013)... Volume based manufacturing savings have allowed Premier ... of both it's WHEY TOO GOOD Vanilla and WHEY ... Health’s whey protein shake drink mixes are ... to help maintain healthy blood sugar levels, increase energy, ... process. , Ideal for health conscious people interested ...
(Date:6/20/2013)... 20, 2013 Millions of Britons are ... medical conditions because they do not brush their teeth ... Elgydium toothpaste. , Seven million Britons do not clean ... between brushes, latest data from the British Dental Health ... polled by the BDHF also admitted that they forgot ...
(Date:6/20/2013)... (PRWEB) June 20, 2013 Michigan-based natural ... research work by chemist David R Hamilton which revealed ... or planned – resulted in the release of the ... entire body. Oxytocin is known as the ‘cardio protective’ ... in turn, good for heart health. , “Being kind ...
(Date:6/20/2013)... 20, 2013 Startups who need to ... sales or test new markets, and international companies that ... a new sales outsourcing company to help ... , Strategy Sales Partners is a collaboration ... business owners for business owners, Strategy Sales Partners increases ...
Breaking Medicine News(10 mins):Health News:Lisa Kroulik Empowers Women to Recognize Emotional Abuse in Intimate Relationships 2Health News:Premier Natural Health, a Leading Provider of Natural Food Products and Herbal Solutions, Reduces Prices On Its Popular Whey Protein Product 2Health News:Premier Natural Health, a Leading Provider of Natural Food Products and Herbal Solutions, Reduces Prices On Its Popular Whey Protein Product 3Health News:Millions Are Risking Gum Disease, Warn Eludril And Elgydium 2Health News:Millions Are Risking Gum Disease, Warn Eludril And Elgydium 3Health News:Kindness Can Be Good for The Heart Says BioGirl Health Show 2Health News:Kindness Can Be Good for The Heart Says BioGirl Health Show 3Health News:Strategy Sales Partners Launches to Provide Sales Outsourcing Assistance to Businesses 2Health News:Strategy Sales Partners Launches to Provide Sales Outsourcing Assistance to Businesses 3
... in high-expenditure ones, study shows , , TUESDAY, May 27 ... care don,t improve patients, perceptions of the care they ... Medicare beneficiaries. , Per capita spending on Medicare beneficiaries ... health don,t account for this variations, said the ...
... suggests they may help cancer cells resist chemo, radiation ... review of existing research suggests that cancer patients undergoing ... antioxidants. , Although multivitamins may be all right in ... E supplements can spell trouble, said review author Dr. ...
... to describe a chemistry lab. But thanks to a ... is a step closer to being green. , ... Tel Aviv University has discovered a way to use ... of chemical reactions more environmentally-friendly. , Prof. Vigaloks ...
... Ensign,Group, Inc. (Nasdaq: ENSG ), the parent ... care services and assisted living,companies, announced today that ... Annual Spring Investor Conference on May 29, 2008 ... Christensen, CEO, together with Alan,Norman, CFO and Greg ...
... CDD,s software will provide the infrastructure for MRF,s collaborative ... ... BURLINGAME, Calif., May 27 Collaborative Drug,Discovery, Inc. (CDD) announced ... help scientists advance new drug,candidates, has been selected by the ...
... difficile infection following operations for which a "prophylactic" antibiotic ... now than it was just a decade ago, according ... They report their findings in the June 15 issue ... operations that have been associated with severe infections, such ...
Cached Medicine News:Health News:Spending Doesn't Improve Patients' Perception of Care 2Health News:Cancer Patients Should Steer Clear of Antioxidants 2Health News:Cancer Patients Should Steer Clear of Antioxidants 3Health News:1 small step for a lab science, 1 green leap for mankind 2Health News:The Ensign Group to Present at the FBR Capital Markets 12th Annual Spring Investor Conference on May 29th 2Health News:The Ensign Group to Present at the FBR Capital Markets 12th Annual Spring Investor Conference on May 29th 3Health News:Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership 2Health News:Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership 3Health News:Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership 4Health News:The balance shifts 2
... protection Properly manufactured radiation protective eyewear ... Our high quality frames and materials offer ... weight. Our lenses are made of Schott ... industry standards. Most Pulse Glasses are offered ...
... Both lenses and frames are designed with ... mind. Our lenses are Schott RS-520 (also called ... shielding glass. These lenses meet standards, as set ... prism correction. ,While our eyewear is protecting ...
... designed with the safety and comfort of the ... (also called SF-6) leaded glass, the industry standard ... as set for optical clarity, visible light transmission, ... is protecting your eyes, it also helps you ...
... are designed with the safety and comfort of ... RS-520 (also called SF-6) leaded glass, the industry ... standards, as set for optical clarity, visible light ... eyewear is protecting your eyes, it also helps ...
Medicine Products: